Key Developments: Sankyo Co Ltd (6417.T)

6417.T on Tokyo Stock Exchange

3,965JPY
23 Jul 2014
Price Change (% chg)

¥-15 (-0.38%)
Prev Close
¥3,980
Open
¥3,995
Day's High
¥4,010
Day's Low
¥3,960
Volume
190,300
Avg. Vol
296,998
52-wk High
¥5,090
52-wk Low
¥3,720

Search Stocks

Latest Key Developments (Source: Significant Developments)

Sankyo Co Ltd lowers consolidated full-year forecast for FY 2014
Wednesday, 5 Feb 2014 01:00am EST 

Sankyo Co Ltd:Sees consolidated full-year revenue of 160,000 million yen for the fiscal year ending Mar. 31, 2014, compared to the previous forecast of 200,000 million yen.Sees operating profit of 28,000 million yen, compared to the previous forecast of 32,000 million yen.Sees ordinary profit of 30,000 million yen, compared to the previous forecast of 34,000 million yen.Sees net profit of 23,000 million yen, compared to the previous forecast of 25,000 million yen.Sees earnings per share of 246.06 yen, compared to the previous forecast of 267.46 yen.Says this is due to decreased sales.FY 2014 revenue of 189.67 million yen and net profit of 25.53 million yen - Thomson Reuters I/B/E/S.  Full Article

Sankyo Co Ltd Amends Consolidated Mid-year Outlook for FY 2014
Tuesday, 6 Aug 2013 02:10am EDT 

Sankyo Co Ltd announced that it has lowered its consolidated mid-year outlook for revenue from JPY 120,000 million to JPY 102,000 million, but affirmed the outlook for operating profit of JPY 25,000 million, ordinary profit of JPY 26,000 million, net profit of JPY 20,000 million and earning per share of JPY 213.96 , for the fiscal year ending March 2014. The Company lowered the revenue outlook due to the decreased sales, among others.  Full Article

Sankyo Co Ltd Lowers Consolidated Full-year Forecast for FY 2013; Affirms Year-end Dividend Forecast for FY 2013
Tuesday, 26 Feb 2013 01:10am EST 

Sankyo Co Ltd announced that it has lowered the consolidated full-year forecast for revenue from JPY 123,000 million to JPY 103,000 million, operating profit from JPY 12,000 million to JPY 4,500 million, ordinary profit from JPY 14,000 million to JPY 6,500 million, net profit from JPY 8,000 million to JPY 3,500 million and earning per share from JPY 85.59 to JPY 37.44 for the fiscal year ending March 31, 2013. The Company lowered the consolidated full-year outlook due to delayed delivery of products. The Company has affirmed the year-end dividend forecast of JPY 75 per share for the fiscal year ending March 31, 2013.  Full Article

Sankyo Co Ltd Lowers Full-year Consolidated Outlook and Reaffirms Year-end Dividend Forecast for FY 2013
Monday, 5 Nov 2012 01:00am EST 

Sankyo Co Ltd announced that it has lowered its full-year consolidated outlook for revenue from JPY 210,000 million to JPY 123,000 million, operating profit from JPY 50,000 million to JPY 12,000 million, ordinary profit from JPY 53,000 million to JPY 14,000 million, net profit from JPY 35,000 million to JPY 8,000 million, and earnings per share from JPY 374.44 to JPY 85.59, for the fiscal year ending March 31, 2013. The Company lowered its full-year consolidated outlook mainly due to the decrease in sales of pachinko machinery and pachislo machinery businesses. The Company also has reaffirmed its year-end dividend forecast of JPY 75 per share, for the same fiscal year.  Full Article

Sankyo Co Ltd Lowers Mid-year Consolidated Outlook for FY 2013
Thursday, 13 Sep 2012 02:00am EDT 

Sankyo Co Ltd announced that it has lowered its mid-year consolidated outlook for revenue from JPY 73,000 million to JPY 52,500 million, operating profit from JPY 13,000 million to JPY 5,200 million, ordinary profit from JPY 14,000 million to JPY 6,200 million, net profit from JPY 10,000 million to JPY 3,700 million, and earnings per share from JPY 106.98 to JPY 39.58, for the fiscal year ending March 2013. The Company lowered its mid-year consolidated outlook mainly due to the decrease in sales estimated for gaming machinery.  Full Article

Update-Moody's: Daiichi Sankyo Will Benefit from Sun Pharma's Acquisition of Ranbaxy

Sun Pharmaceutical Industries Ltd (Sun Pharma) & Ranbaxy Laboratories Ltd (Ranbaxy)

Search Stocks